News

SaaS adoption in clinical trials raises data security and regulatory compliance questions for sponsors using cloud-based platforms.

Federal funding cuts and regulatory changes intensify trial complexity at clinical research sites entering 2025, threatening study timelines and...

DSMB recommends continuing 60 Degrees' tafenoquine trial for chronic babesiosis after safety review of interim data through Day 30.

400 clinical researchers release AI Benchmarking Report for trial operations, establishing industry baseline standards for sponsor and site adoption.

Only 11% of pharma firms have fully implemented AI in clinical trials as of late 2024, according to WCG's...

Can-Fite's namodenoson met safety goals in Phase 2a pancreatic cancer study, with third-line patients showing median survival exceeding five...

Imviva gains FDA clearance for clonoSEQ in CTD402 T-ALL trial, enabling MRD-driven patient management decisions in allogeneic CAR-T therapy...

Brii Bio's ENRICH study demonstrates 42.9% HBsAg loss in hepatitis B patients, but Phase 3 advancement faces legal constraints...

Revolution Medicines reports 82% response rate for zoldonrasib in metastatic pancreatic cancer, with Phase 3 trials underway in first-line...

Abbisko and AstraZeneca begin Phase I/II trial combining lumipodlin with osimertinib in EGFR-mutant NSCLC patients with high PD-L1 expression.